ClinicalTrials.Veeva

Menu

The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation. (CE)

A

Air Force Military Medical University of People's Liberation Army

Status

Unknown

Conditions

Ischemic Stroke

Study type

Observational

Funder types

Other

Identifiers

NCT02181374
Xijing-25

Details and patient eligibility

About

The purpose of this study is to evaluate the diagnostic value of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion.

Full description

All included in the cases in 7 days of blood samples, the detection of serum NT - proBNP.Through the single factor analysis to determine the serum NT - proBNP central source sex stroke prediction values.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 ≤ Age ≤ 85;
  • Meet the clinical diagnostic criteria for acute ischemic stroke;
  • onset within 7 days;

Exclusion criteria

  • Severe systemic disease (chronic inflammation, infection, blood system diseases, cancer, kidney failure, liver failure,heart failure);
  • Nearly a month history of myocardial infarction;
  • pregnant;
  • Serious neurological disease that the diagnosis is unclear;

Trial contacts and locations

1

Loading...

Central trial contact

Wen Jiang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems